
Massive Bio is an AI-powered platform that connects cancer patients with clinical trials, enhancing access to life-saving treatments. The company leverages advanced technology and real-time data to…

Massive Bio is an AI-powered platform that connects cancer patients with clinical trials, enhancing access to life-saving treatments. The company leverages advanced technology and real-time data to…
What they do: AI platform that matches cancer patients to clinical trials and provides concierge enrollment support
Founded: 2014–2015 (company sources list both years)
Headquarters: New York City
Reported patients: Tens of thousands of onboarded cancer patients (reported figures: ~60,000; another source: 160,000)
Total funding (reported): Approximately $23.8M reported across disclosed rounds
Oncology clinical-trial access and patient recruitment
2014
Hospitals and Health Care
2600000
Company reported a $2.6M financing led by Revo Capital
9000000
Company reported a $9M round to scale growth and global expansion
“Includes development finance institutions, venture investors, and philanthropic backers (examples named in disclosures: DEG, IFC, Revo Capital, Charles & Lynn Schusterman Family Philanthropies)”
| Company |
|---|
About Massive Bio Every cancer patient deserves access to treatment options. Massive Bio is an AI-powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating the barriers of geography, financial constraints, and information asymmetry that have historically limited enrollment.
Founded in 2015 and headquartered in US, Massive Bio is scaling its impact globally by powering operations across multiple countries and bringing innovative cancer treatment options to a rapidly growing and diverse population of patients. Through our proprietary AI platform, we connect individuals to clinical trials worldwide and partner with leading pharmaceutical companies, contract research organizations (CROs), and healthcare systems to accelerate drug development and expand equitable access to cutting-edge therapies.
We're recognized as a leader in health-tech innovation. Massive Bio was featured as #4 in Fast Company's Startup 100 list for Turkey and has raised $24M total funding from impact-driven investors including Revo Capital, the International Finance Corporation, and Cavendish Impact Foundation, validating both our business model and our mission-driven approach.
About The Role As the primary owner of sponsor and biopharma client relationships, you’ll play a key part in shaping customer experience and driving delivery. You’ll lead client meetings, translate asks into actionable plans, and work cross-functionally to ensure commitments are met on time and with quality. This is a sponsor-facing delivery role (not business development), success is measured by execution quality, responsiveness, and sponsor outcomes. You’ll embody best-in-class Customer Success and Account Management—where executive presence, fluent English, real-time handling of challenging questions, and thorough follow-up set the standard.
Key Responsibilities
Qualifications & Requirements
Powered by JazzHR
kbvYuQG5SY
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week